C Partners Holding Gmb H Eli Lilly & CO Transaction History

C Partners Holding Gmb H

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 07, 2019	SELL	$105.9 - $118.64 $125,915 - $141,062	-1,189 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$85.86 - $107.31 $126,901 - $158,604	-1,478 Reduced 55.42%	1,189 $128,000
Q2 2018 Aug 14, 2018	SELL	$75.7 - $86.88 $5,147 - $5,907	-68 Reduced 2.49%	2,667 $228,000
Q1 2018 May 15, 2018	SELL	$74.21 - $87.6 $34,730 - $40,996	-468 Reduced 14.61%	2,735 $212,000
Q4 2017 Feb 14, 2018	BUY	$81.94 - $87.89 $262,453 - $281,511	3,203	3,203 $271,000

4,010

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $760B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of C Partners Holding Gmb H, based on Form 13F filings with the SEC.

Stay updated on C Partners Holding Gmb H with notifications on news.